C9ORF72-associated Motor Neuron Disease patients feature abnormal expression of 5 dipeptide repeat (DPR) polymers. Here we used quantitative proteomics in a Neuro2a cell model to demonstrate that the valency of Arg in the most toxic DPRS, PR and GR, drives promiscuous binding to the proteome, compared to a relative sparse binding of the more inert AP and GA. Notable targets included ribosomal proteins, translation initiation factors and translation elongation factors. PR and GR comprising more than 10 repeats robustly stalled the ribosome suggesting high-valency Arg electrostatically jams the ribosome exit tunnel during synthesis. Poly-GR also bound to arginine methylases and induced hypomethylation of endogenous proteins, with a profound destabilization of the actin cytoskeleton. Our findings point to arginine in GR and PR polymers as multivalent toxins to translation as well as arginine methylation with concomitant downstream effects on widespread biological processes including ribosome biogenesis, mRNA splicing and cytoskeleton assembly. SIGNIFICANCE STATEMENT. The major genetic cause of MND are mutations in an intron of the C9ORF72 gene that lead to the expansion in the length of a hexanucleotide repeat sequence, and subsequent non-AUG mediated translation of the intron into 5 different DPRs. The two DPRs containing Arg are potently toxic in animal and cell models. Our research shows that the valency of Arg mediates widespread proteome binding especially affecting machinery involved
INTRODUCTION
The major genetic cause of motor neuron disease (MND) (also known as amyotrophic lateral sclerosis (ALS)) and frontotemporal degeneration (FTD) is an expansion in the number of GGGGCC hexanucleotide repeats in C9ORF72 from less than 15 in the general population to over 20 (and typically hundreds) (1) (2) (3) (4) . Toxicity has been proposed to arise through multiple mechanisms including C9ORF72 haploinsufficiency (2) , the formation of C9ORF72 mRNA foci that sequesters critical RNA binding proteins (5) (6) (7) (8) (9) (10) and the production of abnormal translation products by non-AUG-initiated translation (RAN translation) (11) . RAN translation occurs from expanded hexanucleotide repeat lengths in both sense and anti-sense transcripts resulting in abnormal expression of 5 dipeptide repeats (DPRs) in neurons of patient brains: poly-GP, poly-GA, poly-GR, poly-AP and poly-PR (5, 8, 12, 13) .
Experimental animal and cell culture models expressing the DPRs have revealed poly-GR and poly-PR to be particularly toxic, with the others being comparatively inert (14) (15) (16) (17) .
Furthermore, while all DPRs are widely distributed in human brain of patients with ALS, only poly-GR is correlated to clinically related regions (18) . Various interactome studies have indicated that the poly-GR and poly-PR DPRs engage with RNA binding proteins, ribosome machinery and proteins with low complexity domains, which mediate the formation of membrane-less organelles by phase separation (17, 19, 20) . These interactions negatively impact on the functioning of ribosome biogenesis (21) , ribosome activity (22) , nucleolus function (21, 23) , nucleocytoplasmic transport (24, 25) and stress granule dynamics (17, 19, 23) .
Here we sought to probe the role of the poly-GR and poly-PR DPRs expressed in a simple cell model by defining what they interact with using quantitative proteomics and examining how the valency of short DPR lengths (10× repeats) differed to longer lengths (101× repeats). Our proteomics data suggested potent engagement of poly-PR and poly-GR to ribosome and translational machinery. Given that poly-GR and poly-PR suppress protein translation, we sought to explore the role of the interactions of ribosomes further (17, 19, 20, 22) . Here we show that the mechanism to account for disruption of protein translation is by poly-PR and poly-GR with high Arg-valency selectively stalling ribosomes during their synthesis. We also reveal secondary key mechanisms mediating poly-PR and poly-GR toxicity. This includes destabilization of the actin cytoskeleton and proteome arginine hypomethylation. Our findings point to multivalent arginine sequences in the DPRs as promiscuous binders to the proteome that in turn enact multiple modes of toxicity.
RESULTS
Expression constructs of the DPRs were synthesized using mixed codons and an ATG-start codon, designed to minimize the influence of RNA-mediated effects from the repeat sequences. 10× and 101× repeat lengths of the toxic poly-PR and poly-GR, as well as the less toxic polyGA and polyAP, were prepared.
These constructs displayed patterns of localization and toxicity in the mouse neuroblastoma cell line Neuro2a similar to that described previously in other models (26) (27) (28) (29) (30) (31) and observed in vivo for cases of MND with C9ORF72 mutation (5, 8, 13, 32, 33) . This included a predominately nuclear punctate pattern of localization for PR10 and PR101 with residual expression in the cytosol (Fig 1A) . The longer repeat length accentuated the localization into the nuclear foci.
GR10 also formed nuclear foci and appeared almost identical to PR10, however GR101 was excluded from the nucleus and had a mostly diffuse cytoplasmic distribution. By contrast, GA10, AP10 and AP101 were slightly enriched in the nucleus without forming distinct puncta. Similarly, GA101 was enriched in the nucleus but also formed large cytosolic (and less commonly nuclear) inclusions in many cells. All DPR constructs expressed at levels comparable to that of GFP except for PR101 and GR101 that have very weak expression levels; about 30% lower than that of either GFP or other long DPRs (Fig 1B) . According to cell survival rates when expressing the DPRs, the poly-PR and poly-GR constructs were most toxic and this was true in both 10× and 101× lengths (Fig 1C) . In contrast, poly-GA was only toxic in 101× lengths and the other DPRS were not toxic. With the model system established, we next sought to investigate how the toxic 101× length DPRs (poly-GR, poly-PR and poly-GA) interacted with the proteome. To do this we transiently transfected cells with GFP or the 101× DPRs fused to GFP and then captured proteins that bound to the DPRs by immunoprecipitation with GFP trap. Proteins were assessed by quantitative proteomics by comparing the pulldowns to GFP-only transfected cells, with protein levels normalized to protein mass recovered from the immunoprecipitation. Under these conditions, GFP levels were anticipated to differ in the pulldown due to different expression levels (Fig 1B) . Indeed, the amount of GFP appeared heavily enriched in the GFPonly control for the toxic DPRs (PR101, GR101 and to a lesser extent GA101) (Fig 2A) . Yet, despite the larger amount of GFP coming from the control GFP-only transfected cells (which would enrich for non-specific interactors to GFP), we observed many proteins strongly enriched to the Arg-rich DPRs and comparatively few for GA101 and AP101 (Fig 2A; Table S1 ). The result suggested two conclusions. One was that the Arg appears to mediate promiscuous binding to the proteome and the second was that these interactions are responsible for mitigating toxicity. The Arg-rich DPRs in particular enriched for proteins involved in ribosome biogenesis and RNA splicing machinery, which is consistent with prior findings (17, (34) (35) (36) . However, we also found additional novel interactions with proteins involved in ribosome-translation, cytoskeleton and chromatin machineries (Fig 2B) . GR101 also enriched specifically for methylosome proteins and PR101 with mitochondrial proteins. GA101, which is the only DPR that formed large cytosolic inclusions, was enriched for a very distinct proteome, indicative of a quite distinct set of molecular mechanisms involved in its more modest toxicity.
It was previously reported that Arg-rich DPRs can cause translational suppression although a mechanism that remains undetermined (37) . Our proteomics data revealed the ATP-binding cassette sub-family E member 1 (ABCE1) was enriched in the PR101 interactome. ABCE1 is involved in translation termination ribosomal recycling (38) , which led us to wonder whether synthesis of the Arg-rich DPRs impairs translation. To examine this possibility we employed a previously established assay to measure the ability of a protein sequence to stall or delay protein synthesis rates (39) . This assay involves a cassette containing two fluorescent reporters on each side of the peptide sequence to be tested for stalling (GFP at the N-terminus and mCherry at the C-terminus) (Fig 3A) . Each construct is encoded in frame without stop codons.
However the test sequence is flanked by viral P2A sequences, which causes the ribosome to skip the formation of a peptide bond but otherwise continue translation elongation uninterrupted. This means that complete translation of the cassette from one ribosome will generate three independent proteins (GFP, test protein, and mCherry) in an equal stoichiometry. However, should the ribosome stall during synthesis, mCherry is produced at lower stoichiometries than the GFP (Fig 3A) .
Compared to previously validated FLAG-tagged stalling reporters that either contain 21 AAA codons (which therefore encodes poly-lysine) to stall, or no AAA codons to allow read-through (39) , GR101 and PR101 constructs induced marked stalling (Fig 3B) . This was DPR-lengthdependent in that the 10× repeats showed no stalling (Fig 3C) . In addition, the AP101 and GA101 did not lead to stalling (Fig 3C) . Indeed, there was a significantly increased ratio of mCherry to GFP (Fig 3C) . A likely explanation for this increased ratio comes from intermolecular FRET arising from low rates of translational readthrough of the stall construct and self-association of these read-through protein products. This was more evident in another control construct of mutant Huntington exon 1 (Httex1), which when containing a polyglutamine (polyQ) expansion above 36 glutamines causes Huntington Disease and becomes highly aggregation prone (40, 41) . The expanded polyQ forms of Httex1 did not cause stalling (Fig 3D) . However, increased pathological lengths of polyglutamine increased the ratio of GFP to mCherry. Microscopic images confirmed the presence of GFP and mCherry in aggregates in cells expressing the GA101 and Httex1 reporters (Fig S1) .
We next sought to examine whether the interactomes of the Arg-rich DPRs were dependent on the valency of arginine (Fig 4A) . For this analysis, we measured the relative enrichment of the interacting proteins (101× versus 10×) in each GO term significantly associated with the Arg-rich DPRs of both lengths. (The enrichment data of 10× DPRs compared to GFP-control are shown in Fig S2) . Almost all GO terms were significantly enriched to the longer Arg-rich DPRs and all were enriched once the relative abundance of the DPRs in the immunoprecipitations was considered (Fig 4A) . These data therefore suggest arginine valency generally mediates the binding. We also saw enrichment patterns consistent with different cellular localizations of 10× and 101× PR constructs (as shown in Fig 1) . In particular, the PR101 DPR revealed a substantial enrichment of proteins in GO terms relevant to nucleus localization (including DNA replication, positive regulation of transcription) which was consistent with the enhanced localization of PR101 to nucleolar substructures compared to PR10 (Fig 4A) . While the actin-related GO terms were enriched also for the Arg-rich DPRs, the enrichment correlated with the DPR localization in the cytosol where most actin is expected to reside. Namely, there was a lesser enrichment for PR101 compared to PR10, in accordance with the shift from more diffuse nuclear and cytoplasmic localization into the nucleolar substructures. GR101 was also excluded from the nucleus compared to GR10, and this was reflected in the greater enrichment of GR101 with actin related GO terms.
Next, we examined how proteome abundances changed in cells expressing the 100× DPRs.
Because the DPRs were toxic and had variable expression levels, we sorted transfected cells into similar levels of expression by virtue of GFP levels before analysis. Cell lysates were collected and quantitatively analyzed by a reductive dimethyl labeling proteome analysis approach (Fig S3A) . The poly-GR and poly-PR DPRs resulted in the most changes to the proteome in accordance with them having a more potent toxicity and promiscuous pattern of interactions. Poly-GR and poly-PR also had many overlapping GO terms annotated consistent with the Arg-valency driving a similar pathological consequence (Fig S3B) . Conversely the nontoxic poly-AP resulted in few changes to the proteome abundance and poly-GA had a distinct signature consistent with a different mechanism of toxicity.
Next we examined whether the enrichment with actin GO terms had a functional consequence for the actin cytoskeleton. The Arg-rich DPRs had a significant impact on the formation of filamentous (F) actin compared to the other DPRs and GFP-alone control using a flow cytometry protocol for measuring free and globular (G) actin ratios (Fig 4B) . There was no apparent co-localization of actin to the DPRs, certainly not to punctate structures of the DPRs (Fig 4C) . However, it was clear that F actin was reduced in individual cells expressing the Argrich DPRs (Fig 4C) . Therefore, the results collectively suggested that the Arg-rich DPRs led to the binding and destabilization of machinery involved in actin filament assembly.
Arginine methylation has been reported to be abnormal in patients with C9ORF72 mutations, including the presence of arginine-dimethylated enriched inclusions (42, 43) . Arginine residues are commonly methylated to regulate biological activity of many cellular processes and are important in particular in histones which are enriched GO terms in our datasets. In addition, abnormal histone methylation has previously been reported in a mouse model of PR50 (44) .
Furthermore, prior work has suggested that arginine methylase PRMT5 is important in regulating stress granule function in C9ORF72 models of disease, and methylates ALS-gene risk factor FUS (42) . Here, GR101 was found to be significantly enriched for 3 proteins in the Methylosome GO term (GO:0034709) including arginine methylases PRMT1 and PRMT5 ( Fig   2B) . PRMT1 appears particularly important, accounting for 85% of the methylation activity in mammalian cells (45) .
This led us to hypothesize that the Arg-rich DPRs interfere with endogenous arginine methylation activity, that links to the mechanisms of ALS toxicity. To test this hypothesis, we examined the 101× DPRs affected proteome levels and corresponding levels of arginine methylation. Because of our reductive dimethylation proteomics workflow, we could only observe a minor fraction of possible arginine methylation patterns that could exist. However, sufficient information was obtained to reveal that GR101 leads to a significantly lower level of arginine methylation relative to the GFP only control (Fig 5A; Table S3 ). These same proteins did not show a significant change in abundance (Fig 5A) . Examination of these peptides revealed that many come from Hnrnp family proteins including Hnrnpa1, Hnrnpab and Hnrnph1 (Table S3 ). Hnrnpa1 showed a statistically significant reduction in Arg-methylation in the PR101 treatment (Fig 5B) . Hnrnp family proteins are well known substrates of PRMT family proteins (46) . Mutations in Hnrnpa1 also cause ALS (47) .
Analysis of the interactome data showed that the Arg-rich DPRs were significantly enriched in interacting with other arginine-enriched proteins (Fig 5C) . These data suggest the possibility that the Arg-rich DPRs act as substrate sinks of arginine methylases that therefore results in a broader deficiency in arginine methylase modification of endogenous proteins.
DISCUSSION
Here we show that the Arg-rich DPRs lead to widespread proteome interactions relative to the other less toxic DPRs. These interactions centre on various hubs of cellular activity including translation, ribosome biogenesis, chromatin, mitochondria, cytoskeleton, RNA splicing and the methylsome. We show that the effects appear driven by the valency of arginine as well as changes in the cellular localization of the different lengths of DPRs. In contrast the inert and non-toxic AP DPRs showed few interactions. GA also showed relative few interactors and unmasked a distinct interactome, consistent with a different mechanism of toxicity to the potently toxic Arg-rich DPRs.
Our key finding was that the Arg-rich DPRs manifest toxicity through multiple mechanisms.
One mechanism of toxicity is their synthesis leading to a stall in translation. Our study suggests that the Arg-rich DPRs longer than at least 10 repeats are needed to induce stalling. Given that the ribosome exit tunnel holds around 33 amino acids and is lined in negative charges, a plausible explanation for stalling is that DPR lengths approaching 16-17 repeat lengths would be sufficient to fill this cavity volume and lock the peptide in place by electrostatic interactions.
Previously it was suggested that a canonical polyadenylate tail on mRNA used to stall ribosomes is translated to lysine, and that the poly-lysine sequence is recognized as aberrant by ribosomes and results in translation repression (48) . Additional experiments using repeating sequences of Lys and Arg in proteins both slowed translation, which supports the mechanism of electrostatic interactions jamming the emergent poly-basic chain in the negatively charged ribosome exit tunnel (49) . Interestingly, antimicrobial peptides enriched for PR-containing motifs have been demonstrated to bind to the ribosomal exit tunnel and inhibit bacterial protein synthesis (50) . This raises the possibility that emergent DPRs can also re-enter and plug the exit tunnel through electrostatic interactions. Further support for this additional mechanism comes from in vitro translation assays showing that poly-PR and poly-GR peptides formed insoluble complexes with mRNA, restricted the access of translation factors to mRNA, and blocked protein translation (51) . This study showed that poly-PR and poly-GR inhibit protein translation by binding to the translational complex and ribosomal proteins, leading to neurotoxicity (51) .
Our data also suggested that the Arg-rich DPRs impede assembly of the actin cytoskeleton.
Recently it was observed that promoting actin filament assembly in cell models of ALS can alleviate defects in nuclear-cytoplasmic transport defects (52) which supports the conclusion that destabilization of the actin cytoskeleton is pertinent to disease pathomechanisms. We observed a significant reduction in F-actin in cells with Arg-rich DPRs. Whether this effect is a consequence of other cellular effects, such as hypomethylation or ribosome stalling is unclear.
Interestingly it has been reported that arginine methylation of an arginine methylase (PRMT2) regulates the activity of actin nucleator protein Cobl, which suggests a possible role for arginine methylation defects being an upstream mediator of effects on the actin cytoskeleton (53) . In addition, it is thought that dysregulation of actin is a key process in ALS (54) . Of note is that mutations in profilin-1 protein, which mediates conversion of G-actin to F-actin, is linked to ALS (55). Other cytoskeletal genes have also been linked to ALS including TUBA4A and DCTN1 and KIF5A (56, 57) .
Our other major finding was that the Arg-rich DPRs led to a broader hypomethylation of the proteome. Previous studies have shown that PRMT1 colocalizes with GR and PR in a Drosophila model and that knockdown of PRMT family members enhanced toxicity (58) . It was also found that C9ORF72-related brain samples had abundant methylated inclusions (58) . Thus, the data suggests that the Arg-rich motifs attract and alter the endogenous methylation activity leading to pathological outcomes. The substrate of PRMT family proteins contain glycine-and argininerich (GAR) sequences that include multiple arginines in RGG or RXR contexts, which bear resemblance to the Arg-rich DPRs (59) . It follows that many of the key pathways seen in our dataset are affected by altered arginine methylase activity -including proteins that are methylated for functional regulation such as histones, proteins involved in mRNA splicing, and ribosomes (60, 61) .
Also of note is that other genes that when mutated are risk factors for ALS have activity regulated by arginine methylation and show abnormal methylation patterns in disease. In particular FUS has been reported to interact with PRMT1 and PRMT8 and undergo asymmetric dimethylation in cultured cells (62) . Importantly, PRMT1 and PRMT8 localized to mutant FUSpositive inclusion bodies in ALS (62) . It has also been reported that arginine methylation modulates the nuclear import of FUS and inclusions in ALS-FUS patients contain methylated FUS (63) . We observed the hypomethylation of Hnrnpa1 caused by the arg-rich DPRs, which indicates a possible link to ALS arising from distinct gene mutations. Hnrnpa1 as well as the Arg-rich DPRs and other ALS-associated proteins are known to form molecular condensates by phase separation (57, 64) . Arginine methylation of Hnrnpa1 reduces its ability to phase separate suggesting that an imbalance in molecular condensate mechanisms contributes to the pathogenic response (65) . PR DPRs can also promote the aggregation of ALS-related proteins containing prion-like domains, that are involved in mediating phase separation into molecular condensates (64) 
MATERIALS AND METHODS
An expanded description of the methods are provided in Supplementary Methods.
Plasmids
Synthetic genes for short (10×) and long (101×) dipeptide repeats were synthesized by GeneArt (Life Technologies, Regensburg, Germany) and cloned into pEGFP-C2 to create GFP fusions.
The full sequence information is available (Table S4) .
Cell culture
Neuro-2a and HEK293T cells, obtained originally from the American Type Culture Collection (ATCC), were maintained in Opti-MEM (Life Technologies) and Dulbecco's modified Eagle medium (DMEM) (Life Technologies), respectively.
Flow cytometry
For analysis of DPR expression levels, cells were harvested 48 hr post-transfection and analysed using LSRFortessa X-20 flow cytometer (BD Biosciences). For GFP, data were collected with the 488-nm laser and FITC (530/30) filter. For SYTOX Red dead cell stain, fluorescence was collected using 640-nm laser and APC (670/14) filter.
Confocal Imaging
Cells expressing GFP-tagged DPRs were fixed 48h after transfection in 4 % paraformaldehyde for 15 min at room temperature. Nuclei were counterstained with Hoechst 33342. Cells were imaged on a Leica SP5 confocal microscope using HCX PL APO CS 40× or 63× oil-immersion objective lens (NA 1.4) at room temperature.
Longitudinal live cell imaging
Neuro-2a cells in 12-well plate format were co-transfected with individual GFP-tagged DPRs along with mCherry cloned into a pT-Rex vector (Life Technologies). The media was refreshed 24 hours after transfection and cells were then imaged longitudinally with a JuLI stage live cell imaging system with fluorescent images acquired at 15 min intervals for 96 h (Nanoentek, Seoul, South Korea). Death was recorded as the time points at which mCherry fluorescence was lost. 
Sample preparation for proteome analysis of GFP-immunoprecipitated samples

Sample preparation for whole proteome analysis
Neuro2a cells expressing GFP-tagged 101× DPRs were harvested 48 h post transfection in PBS with a cell scraper and gentle pipetting. Cells were pelleted and resuspended, supplemented with DAPI and fluorescence-activated cell sorted using a FACS ARIA III cell sorter (BD Biosciences). 1,000,000 cells of each population of interest were recovered using a matched median GFP expression level. Cells were pelleted and snap frozen in liquid nitrogen.
Cell pellets were thawed then lysed in 100 µL RIPA lysis buffer. Proteins were collected by acetone precipitation and resuspended in 100 µL 0.1M TEAB for mass spectrometry analysis
Mass spectrometry analysis
Proteins were subjected to reduction with 10 mM tris(2-carboxyethyl)phosphine (TCEP), pH 8.0, and alkylation with 55 mM iodoacetamide for 45 min, followed by trypsin digestion (0.25 µg, 37 °C, overnight). 10 µg of each proteins were labelled by reductive dimethyl labelling using light formaldehyde (CH2O), medium formaldehyde (CD2O, 98% D) or heavy formaldehyde ( 13 CD2O, 99% 13 C, 98% D) for LC-MS/MS analysis.
Samples (1 μg for whole proteome or 0.135 µg for L peptide) were analysed by liquid chromatography-nano electrospray ionization--tandem mass spectrometry (LC-nESI-MS/MS) using Orbitrap Lumos mass spectrometer (Thermo Scientific, San Jose, CA, USA) fitted with nanoflow reversed-phase-HPLC (Ultimate 3000 RSLC, Dionex). 
Proteomic data analysis
Dual fluorescence translation stall assay
The dual-fluorescence translation stall reporter plasmids were created as described previously, except we used mCherry as the red fluorescent protein moeity (66) . In essence, DPR constructs and Httex1 constructs with different polyQ expansions (25Q, 72Q and 97Q) were cloned to replace the linker region. The fluorescence reporter plasmids were transfected into cells using Lipofectamine 2000 and cells were harvested 2-days afterwards for analysis by flow cytometry (LSRFortessa X-20 flow cytometer, BD Biosciences).
Flow Cytometry analysis of G-and F-actin
F-and G-actin levels in Neuro2a cells were measured as described (67) . Briefly, Neuro2a cells The P2A sequence causes the ribosome to skip the formation of a peptide bond but otherwise continue translation elongation uninterrupted. Complete translation of the cassette from one ribosome will generate three independent proteins (GFP, test protein, and mCherry). However, should the ribosome stall during synthesis (such as through the previously established positive stall reporter sequence with poly-lysine (K20; +ve sequence. The -ve sequence is stall reporter sequence without lysine residues. B. Flow cytograms of Neuro2a cells 48 h after transfection with the indicated test sequences inserted into the reporter. C. Median mCherry:GFP ratios calculated from transfected cells population (from 100,000 analyzed cells). Error bars indicate standard deviations from three independent transfections and flow cytometry measurements. P values determined for one-way ANOVA and Dunnett's post hoc test using the -ve as the control. ****, P<0.0001; ***, P<0.001; ns, P>0.05. D. The same assay (and statistical tests) using Huntington exon 1 (Httex1) transfected in HEK293 cells with the indicated polyglutamine (polyQ) lengths. Table S3 for data). Significance of difference was assessed with an unpaired ttest with Welch's correction. P value is coded as *, P < 0.05. C. Shown are P values of a binomial statistical test for DPR interactomes classified into those with arginine-rich motifs (68) or those lacking such motifs. The P values indicate the probability of the proportion of proteins with R-motifs being equal to or greater than that observed (versus the control proportion). The control proteins are a dataset of random mouse proteins. D. As for C, but for proteins seen significantly upregulated and downregulated in total protein lysate compared to control.
